[Novel class III antiarrhythmic agent niferidile: review of experimental and clinical studies].

@article{Makov2014NovelCI,
  title={[Novel class III antiarrhythmic agent niferidile: review of experimental and clinical studies].},
  author={E B Maĭkov and Iu A Iuricheva and N Iu Mironov and Sergey F Sokolov and Sergey Golitsyn and L. V. Rozenshtraukh and Evgeny I. Chazov},
  journal={Kardiologiia},
  year={2014},
  volume={54 1},
  pages={4-19}
}
This article reviews experimental and clinical studies of a novel antiarrhythmic agent niferidile. Niferidile, a class III antiarrhythmic agent, blocks potassium outward currents, prolongs repolarization and refractory periods predominantly in atria than in ventricles. Intravenous Niferidile was efficient for interruption of AV-nodal and orthodromic re… CONTINUE READING